| Standardized Olive Leaf Capsules; as a Co-therapy in the Treatment of COVID-19 Patients (NCT04873349) | Shimaa M. Abdelgawad | 2021-05-10 |
| Infusional Fluorouracil and Weekly Docetaxel for Gastric Cancer With Bone Marrow Involvement and DIC (NCT04547153) | Sixth Affiliated Hospital, Sun Yat-sen University | 2021-01-15 |
| Study Assessing Efficacy of Plasmatherapy in Septic Shock-induced Coagulopathy: Feasibility Study (NCT04580563) | University Hospital, Strasbourg, France | 2020-10-22 |
| Coagulation Changes Associated With COVID-19 Infection (NCT04460664) | HemoSonics LLC | 2020-08-14 |
| The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 Hospitalizations (NCT04363840) | Louisiana State University Health Sciences Center in New Orleans | 2020-05-01 |
| Analysis of the Coagulopathy Developed by COVID-19 Infected Patients (NCT04356950) | Centre Hospitalier Universitaire de Nīmes | 2020-04-28 |
| Thrombomodulin-modified Thrombin Generation Assay (TGA-TM) in Patients With Critical Infections (NCT04356144) | Medical University of Vienna | 2020-04-15 |
| PLatelets Acetyl-CoA Carboxylase Phosphorylation State in SEPtic Shock (NCT04107402) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2019-03-15 |
| Efficacy and Safety of Unfractionated Heparin on Severe Sepsis With Suspected Disseminated Intravascular Coagulation (NCT02654561) | China Medical University, China | 2018-04-12 |
| International Prospective Registry of Disseminated Intravascular Coagulation (NCT03577015) | Marcella Muller | 2017-11-01 |
| Platelet Reactivity in Septic Shock (NCT03716310) | Università degli Studi di Ferrara | 2017-04-01 |
| Clinical Pharmacokinetics Study of ART-123 in Disseminated Intravascular Coagulation (DIC) Subjects With Renal Impairment (NCT01704001) | Asahi Kasei Therapeutics Corporation | 2012-10-01 |
| Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular Coagulation (NCT00487656) | Artisan Pharma, Inc. | 2007-07-01 |
| Recombinant Human Antithrombin (ATryn®) in the Treatment of Patients With DIC Associated With Severe Sepsis (NCT00506519) | LEO Pharma | 2007-07-01 |